New Delhi,

新德里，

Glenmark Pharmaceuticals

格伦马克制药公司

on Thursday said it will launch a

周四表示将推出一项

generic medication

通用药物

this month in the US market for the treatment of anaemia and to prevent serious side effects caused by large doses of medications that can reduce the impact of folic acid in the body.

本月在美国市场用于治疗贫血，并预防因大剂量药物可能减少体内叶酸影响而引起的严重副作用。

Glenmark Pharmaceuticals Inc.

格伦马克制药公司

, USA, a unit of the company, will start distribution of Leucovorin Calcium for Injection USP, 350 mg/vial single-dose vial this month, the Mumbai-based drug maker said in a regulatory filing.

，美国公司的一个部门本月初开始分销350毫克/瓶的单剂量注射用甲酰四氢叶酸钙USP，这家总部位于孟买的制药商在监管文件中表示。

According to IQVIA sales data for the 12-month period ending October 2025, the product achieved annual sales of around USD 16.8 million.

根据IQVIA截至2025年10月的12个月销售数据，该产品的年销售额达到约1680万美元。

Shares of

股票

Glenmark

格伦马克

were trading 1.23 per cent up at Rs 2,080.30 apiece on the BSE.

在BSE，每股交易价格上涨了1.23％，达到2,080.30卢比。

Add

添加

as a Reliable and Trusted News Source

作为一个可靠和值得信赖的新闻来源

Add Now!

立即添加！

(You can now subscribe to our

（你现在可以订阅我们的

Economic Times WhatsApp channel

经济时报WhatsApp频道

)

)

(You can now subscribe to our

（你现在可以订阅我们的

Economic Times WhatsApp channel

经济时报WhatsApp频道

)

)